Suppr超能文献

使用“GO”报告基因成像系统上的可激活基因评估用于递送腺嘌呤和胞嘧啶碱基编辑器的DNA小环。

Evaluation of DNA minicircles for delivery of adenine and cytosine base editors using activatable gene on "GO" reporter imaging systems.

作者信息

Evans Melissa M, Liu Shirley, Krautner Joshua S, Seguin Caroline G, Leung Rajan, Ronald John A

机构信息

Robarts Research Institute, University of Western Ontario, London, ON N6A 3K7, Canada.

Department of Medical Biophysics, University of Western Ontario, London, ON N6A 5C1, Canada.

出版信息

Mol Ther Nucleic Acids. 2024 Jun 10;35(3):102248. doi: 10.1016/j.omtn.2024.102248. eCollection 2024 Sep 10.

Abstract

Over 30,000 point mutations are associated with debilitating diseases, including many cancer types, underscoring a critical need for targeted genomic solutions. CRISPR base editors, like adenine base editors (ABEs) and cytosine base editors (CBEs), enable precise modifications by converting adenine to guanine and cytosine to thymine, respectively. Challenges in efficiency and safety concerns regarding viral vectors used in delivery limit the scope of base editing. This study introduces non-viral minicircles, bacterial-backbone-free plasmids, as a delivery vehicle for ABEs and CBEs. The research uses cells engineered with the "Gene On" (GO) reporter gene systems for tracking minicircle-delivered ABEs, CBEs, or Cas9 nickase (control), using green fluorescent protein (GFP), bioluminescence reporter firefly luciferase (LUC), or a highly sensitive Akaluciferase (Akaluc) designed in this study. The results show that transfection of minicircles expressing CBE or ABE resulted in significantly higher GFP expression and luminescence signals over controls, with minicircles demonstrating the most substantial editing. This study presents minicircles as a new strategy for base editor delivery and develops an enhanced bioluminescence imaging reporter system for tracking ABE activity. Future studies aim to evaluate the use of minicircles in preclinical cancer models, facilitating potential clinical applications.

摘要

超过30000个点突变与包括多种癌症类型在内的使人衰弱的疾病相关,这突出表明迫切需要有针对性的基因组解决方案。CRISPR碱基编辑器,如腺嘌呤碱基编辑器(ABEs)和胞嘧啶碱基编辑器(CBEs),能够分别通过将腺嘌呤转化为鸟嘌呤以及将胞嘧啶转化为胸腺嘧啶来实现精确修饰。用于递送的病毒载体在效率和安全性方面存在的挑战限制了碱基编辑的范围。本研究引入了无细菌骨架的非病毒微型环作为ABEs和CBEs的递送载体。该研究使用经“基因开启”(GO)报告基因系统改造的细胞,通过绿色荧光蛋白(GFP)、生物发光报告基因萤火虫荧光素酶(LUC)或本研究设计的高灵敏度海肾荧光素酶(Akaluc)来追踪微型环递送的ABEs、CBEs或Cas9切口酶(对照)。结果表明,转染表达CBE或ABE的微型环导致GFP表达和发光信号比对照组显著更高,微型环显示出最显著的编辑效果。本研究将微型环作为碱基编辑器递送的一种新策略,并开发了一种用于追踪ABE活性的增强型生物发光成像报告系统。未来的研究旨在评估微型环在临床前癌症模型中的应用,以促进潜在的临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7b/11260848/02551f7ae350/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验